Free Trial

Trinity Biotech (TRIB) SEC Filings & 10K Form

Trinity Biotech logo
$0.79 +0.01 (+1.54%)
Closing price 03:58 PM Eastern
Extended Trading
$0.76 -0.03 (-3.67%)
As of 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Trinity Biotech SEC Filings

DateFilerForm TypeView
07/01/2025
9:27 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2025
2:03 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2025
7:39 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2025
7:33 AM
Trinity Biotech (Filer)
Form 424B3
03/30/2025
11:15 PM
Trinity Biotech (Filer)
Form EFFECT
03/25/2025
5:29 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Trinity Biotech (Subject)
Form SCHEDULE 13D/A
03/21/2025
4:00 PM
Trinity Biotech (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
03/14/2025
3:30 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2025
6:30 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2025
7:30 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2025
8:00 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2025
7:36 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/29/2025
4:15 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
10:33 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2024
3:14 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2024
3:05 PM
Trinity Biotech (Filer)
Form 424B5
12/26/2024
5:19 PM
New Main Equity Co., Ltd. (Filed by)
Trinity Biotech (Subject)
Form SCHEDULE 13D
12/26/2024
6:12 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
8:55 PM
MiCo IVD Holdings, LLC (Filed by)
Trinity Biotech (Subject)
Form SCHEDULE 13D/A
12/18/2024
11:02 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
3:42 PM
Trinity Biotech (Filer)
Form 424B5
12/05/2024
3:30 PM
Trinity Biotech (Filer)
Form 424B3
12/02/2024
11:15 PM
Trinity Biotech (Filer)
Form EFFECT
11/29/2024
3:45 PM
Trinity Biotech (Filer)
Form F-3/A
11/15/2024
4:00 PM
Trinity Biotech (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
11/15/2024
12:22 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
4:26 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Trinity Biotech (Subject)
Form SC 13D/A
11/07/2024
11:33 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
12:23 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
12:24 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/07/2024
9:35 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2024
10:22 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
2:07 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
5:01 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
7:11 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
4:14 PM
Trinity Biotech (Filer)
Form 424B5
09/10/2024
9:35 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
12:26 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
9:52 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
10:59 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/29/2024
5:01 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
"I'm risking my reputation on this" (Ad)

Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.

Claim your FREE copy of Crypto Revolution now.
08/27/2024
11:33 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/21/2024
3:40 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2024
12:52 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
4:26 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
4:27 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2024
4:03 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2024
3:53 PM
Trinity Biotech (Filer)
Form 424B5
07/11/2024
5:55 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TRIB) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners